Selected second quarter approvals and setbacks

Selected second quarter approvals and setbacks

Company Approval
Actelion Europe approves Tracleer bosentan to treat pulmonary arterial hypertension
Alliance FDA approves Imagent ultrasound contrast agent for cardiac imaging
Andrx FDA approves Altocor extended release lovastatin for cholesterol disorders
Biogen FDA issues complete response letter for Amevive alefacept to treat psoriasis

Read the full 512 word article

How to gain access

Continue reading with a
two-week free trial.